Indications |
Intramuscular Gonorrhoea Adult: 2 g as single dose. In cases whereby antibiotic resistance is prevalent, 4 g (10 ml) may be given but divided as two 5 ml inj, admin to 2 different inj sites. Child: <45 kg: 40 mg/kg as a single dose. ≥45 kg: 2 g as single dose. In cases whereby antibiotic resistance is prevalent, 4 g (10 ml) may be given but divided as two 5 ml inj, admin to 2 different inj sites. Intramuscular Disseminated gonococcal infection Adult: 2 g every 12 hr. Reconstitution: Reconstitute with supplied diluent only. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Repeated doses may lead to changes in the kidney and liver function and a reduction in haemoglobin and haematocrit levels. Prolonged use may result in fungal or bacterial superinfection. All patients with gonorrhoea should be tested for syphilis at the time of diagnosis. |
Adverse Reactions |
Dizziness; nausea; urticaria; chills; fever; headache, insomnia, mild to moderate pain after inj. Potentially Fatal: Anaphylaxis. |
Drug Interactions |
May result in lithium toxicity when used concurrently. See Below for More spectinomycin Drug Interactions |
Mechanism of Actions |
Spectinomycin binds to 30S subunit of the bacterial ribosome, thus inhibiting protein synthesis. It has modest activity against a wide range of gram-positive and gram-negative organisms, though anaerobic organisms are mostly resistant. Absorption: Poorly absorbed after oral admin but rapidly absorbed after IM inj. Distribution: Poor distribution into the saliva. Poorly bound to plasma proteins. Excretion: Excreted in an active form in the urine. Half-life: 1-3 hr; may be prolonged in renal impairment. |
Storage Conditions |
Intramuscular: Store at 20-25°C. Reconstituted solutions should be used within 24 hr after preparation. |
ATC Classification |
J01XX04 - spectinomycin ; Belongs to the class of other antibacterials. Used in the systemic treatment of infections. |
Storage |
Intramuscular: Store at 20-25°C. Reconstituted solutions should be used within 24 hr after preparation. |
Available As |
|
Spectinomycin
Post Review about Spectinomycin Click here to cancel reply.
Spectinomycin Containing Brands
Spectinomycin is used in following diseases
Drug - Drug Interactions of Spectinomycin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.